Summary
95.95 1.62(1.72%)06/17/2024
iRhythm Technologies Inc (IRTC)
iRhythm Technologies Inc (IRTC)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 1.72 | 0.92 | 0.98 | -6.15 | -4.71 | -4.07 | 23.62 | 268.33 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 95.95 | |
| Open | 93.91 | |
| High | 96.12 | |
| Low | 92.45 | |
| Volume | 161,490 | |
| Change | 1.62 | |
| Change % | 1.72 | |
| Avg Volume (20 Days) | 300,286 | |
| Volume/Avg Volume (20 Days) Ratio | 0.54 | |
| 52 Week Range | 70.24 - 124.03 | |
| Price vs 52 Week High | -22.64% | |
| Price vs 52 Week Low | 36.60% | |
| Range | 2.17 | |
| Gap Up/Down | -0.45 | |
Fundamentals | ||
| Market Capitalization (Mln) | 2,884 | |
| EBIDTA | -38,140,000 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 114.80 | |
| Book Value | 10.0550 | |
| Earnings Per Share | -2.6880 | |
| EPS Estimate Current Quarter | -1.1000 | |
| EPS Estimate Next Quarter | -0.9800 | |
| EPS Estimate Current Year | -3.5300 | |
| EPS Estimate Next Year | -3.1000 | |
| Diluted EPS (TTM) | -2.6880 | |
| Revenues | ||
| Profit Marging | -0.2455 | |
| Operating Marging (TTM) | -0.2418 | |
| Return on asset (TTM) | -0.0989 | |
| Return on equity (TTM) | -0.2491 | |
| Revenue TTM | 319,830,016 | |
| Revenue per share TTM | 10.9510 | |
| Quarterly Revenue Growth (YOY) | 0.1870 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 194,889,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 8.9589 | |
| Revenue Enterprise Value | 7.8642 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 29,425,900 | |
| Shares Float | 29,054,542 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 1.70 | |
| Institutions (%) | 99.61 | |
06/17 16:05 EST - globenewswire.com
iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation
SAN FRANCISCO, June 17, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company has successfully launched the initial phases of its previously disclosed manufacturing automation plans, marking a significant corporate milestone expected to set the stage for future growth and innovation while also yielding substantial cost savings.
iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation
SAN FRANCISCO, June 17, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company has successfully launched the initial phases of its previously disclosed manufacturing automation plans, marking a significant corporate milestone expected to set the stage for future growth and innovation while also yielding substantial cost savings.
06/04 16:05 EST - globenewswire.com
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming Truist Securities MedTech Conference.
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming Truist Securities MedTech Conference.
05/22 16:05 EST - globenewswire.com
iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference
SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming William Blair 44th Annual Growth Stock Conference.
iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference
SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming William Blair 44th Annual Growth Stock Conference.
05/20 05:00 EST - https://www.defenseworld.net
Amalgamated Bank Sells 307 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC)
Amalgamated Bank lowered its holdings in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report) by 6.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,396 shares of the company’s stock after selling 307 shares during the quarter. Amalgamated Bank’s holdings in iRhythm Technologies were worth $471,000 as of its most recent filing with the Securities & Exchange Commission. Several other institutional investors have also recently made changes to their positions in IRTC. Victory Capital Management Inc. increased its holdings in iRhythm Technologies by 22.3% during the fourth quarter. Victory Capital Management Inc. now owns 4,070 shares of the company’s stock valued at $436,000 after buying an additional 743 shares during the last quarter. Truist Financial Corp increased its stake in shares of iRhythm Technologies by 7.6% in the 4th quarter. Truist Financial Corp now owns 16,226 shares of the company’s stock worth $1,737,000 after purchasing an additional 1,140 shares in the last quarter. State of New Jersey Common Pension Fund D increased its stake in shares of iRhythm Technologies by 25.8% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 29,300 shares of the company’s stock worth $3,136,000 after purchasing an additional 6,012 shares in the last quarter. Handelsbanken Fonder AB raised its holdings in iRhythm Technologies by 3.3% in the 4th quarter. Handelsbanken Fonder AB now owns 6,239 shares of the company’s stock worth $668,000 after purchasing an additional 200 shares during the period. Finally, WCM Investment Management LLC lifted its position in iRhythm Technologies by 61.4% during the fourth quarter. WCM Investment Management LLC now owns 133,195 shares of the company’s stock valued at $14,497,000 after purchasing an additional 50,673 shares in the last quarter. Wall Street Analysts Forecast Growth Several research analysts have recently commented on the company. JPMorgan Chase & Co. decreased their price objective on iRhythm Technologies from $142.00 to $133.00 and set an “overweight” rating on the stock in a research note on Friday, February 23rd. Canaccord Genuity Group decreased their target price on shares of iRhythm Technologies from $133.00 to $122.00 and set a “buy” rating on the stock in a research note on Friday, May 3rd. Finally, Needham & Company LLC upped their price target on shares of iRhythm Technologies from $137.00 to $138.00 and gave the stock a “buy” rating in a research report on Friday, May 3rd. One research analyst has rated the stock with a sell rating and seven have given a buy rating to the company’s stock. According to MarketBeat, iRhythm Technologies has an average rating of “Moderate Buy” and a consensus target price of $134.00. View Our Latest Stock Report on iRhythm Technologies iRhythm Technologies Trading Down 3.9 % Shares of IRTC opened at $94.83 on Monday. iRhythm Technologies, Inc. has a 1 year low of $70.24 and a 1 year high of $132.92. The company has a 50 day simple moving average of $108.44 and a two-hundred day simple moving average of $104.86. The company has a debt-to-equity ratio of 7.13, a current ratio of 7.10 and a quick ratio of 6.95. The firm has a market cap of $2.95 billion, a P/E ratio of -22.42 and a beta of 1.31. iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last announced its quarterly earnings results on Thursday, February 22nd. The company reported ($1.26) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.66). iRhythm Technologies had a negative net margin of 25.33% and a negative return on equity of 69.87%. The company had revenue of $132.51 million during the quarter, compared to the consensus estimate of $131.14 million. On average, equities analysts expect that iRhythm Technologies, Inc. will post -3.22 earnings per share for the current fiscal year. Insider Buying and Selling In other iRhythm Technologies news, EVP Daniel G. Wilson sold 1,261 shares of the firm’s stock in a transaction that occurred on Thursday, February 29th. The stock was sold at an average price of $121.96, for a total transaction of $153,791.56. Following the completion of the transaction, the executive vice president now owns 32,967 shares in the company, valued at approximately $4,020,655.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other iRhythm Technologies news, EVP Daniel G. Wilson sold 1,261 shares of iRhythm Technologies stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $121.96, for a total value of $153,791.56. Following the completion of the transaction, the executive vice president now directly owns 32,967 shares of the company’s stock, valued at approximately $4,020,655.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CTO Mark J. Day sold 1,475 shares of the company’s stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $121.96, for a total transaction of $179,891.00. Following the sale, the chief technology officer now owns 64,412 shares in the company, valued at $7,855,687.52. The disclosure for this sale can be found here. Over the last three months, insiders have sold 35,052 shares of company stock worth $4,274,942. Corporate insiders own 0.68% of the company’s stock. iRhythm Technologies Company Profile (Free Report) iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. See Also Five stocks we like better than iRhythm Technologies What Investors Need to Know About Upcoming IPOs MarketBeat Week in Review – 5/13 – 5/17 3 REITs to Buy and Hold for the Long Term Take-Two Interactive Software Offers 2nd Chance for Investors The Role Economic Reports Play in a Successful Investment Strategy Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook Want to see what other hedge funds are holding IRTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report).
Amalgamated Bank Sells 307 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC)
Amalgamated Bank lowered its holdings in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report) by 6.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,396 shares of the company’s stock after selling 307 shares during the quarter. Amalgamated Bank’s holdings in iRhythm Technologies were worth $471,000 as of its most recent filing with the Securities & Exchange Commission. Several other institutional investors have also recently made changes to their positions in IRTC. Victory Capital Management Inc. increased its holdings in iRhythm Technologies by 22.3% during the fourth quarter. Victory Capital Management Inc. now owns 4,070 shares of the company’s stock valued at $436,000 after buying an additional 743 shares during the last quarter. Truist Financial Corp increased its stake in shares of iRhythm Technologies by 7.6% in the 4th quarter. Truist Financial Corp now owns 16,226 shares of the company’s stock worth $1,737,000 after purchasing an additional 1,140 shares in the last quarter. State of New Jersey Common Pension Fund D increased its stake in shares of iRhythm Technologies by 25.8% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 29,300 shares of the company’s stock worth $3,136,000 after purchasing an additional 6,012 shares in the last quarter. Handelsbanken Fonder AB raised its holdings in iRhythm Technologies by 3.3% in the 4th quarter. Handelsbanken Fonder AB now owns 6,239 shares of the company’s stock worth $668,000 after purchasing an additional 200 shares during the period. Finally, WCM Investment Management LLC lifted its position in iRhythm Technologies by 61.4% during the fourth quarter. WCM Investment Management LLC now owns 133,195 shares of the company’s stock valued at $14,497,000 after purchasing an additional 50,673 shares in the last quarter. Wall Street Analysts Forecast Growth Several research analysts have recently commented on the company. JPMorgan Chase & Co. decreased their price objective on iRhythm Technologies from $142.00 to $133.00 and set an “overweight” rating on the stock in a research note on Friday, February 23rd. Canaccord Genuity Group decreased their target price on shares of iRhythm Technologies from $133.00 to $122.00 and set a “buy” rating on the stock in a research note on Friday, May 3rd. Finally, Needham & Company LLC upped their price target on shares of iRhythm Technologies from $137.00 to $138.00 and gave the stock a “buy” rating in a research report on Friday, May 3rd. One research analyst has rated the stock with a sell rating and seven have given a buy rating to the company’s stock. According to MarketBeat, iRhythm Technologies has an average rating of “Moderate Buy” and a consensus target price of $134.00. View Our Latest Stock Report on iRhythm Technologies iRhythm Technologies Trading Down 3.9 % Shares of IRTC opened at $94.83 on Monday. iRhythm Technologies, Inc. has a 1 year low of $70.24 and a 1 year high of $132.92. The company has a 50 day simple moving average of $108.44 and a two-hundred day simple moving average of $104.86. The company has a debt-to-equity ratio of 7.13, a current ratio of 7.10 and a quick ratio of 6.95. The firm has a market cap of $2.95 billion, a P/E ratio of -22.42 and a beta of 1.31. iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last announced its quarterly earnings results on Thursday, February 22nd. The company reported ($1.26) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.66). iRhythm Technologies had a negative net margin of 25.33% and a negative return on equity of 69.87%. The company had revenue of $132.51 million during the quarter, compared to the consensus estimate of $131.14 million. On average, equities analysts expect that iRhythm Technologies, Inc. will post -3.22 earnings per share for the current fiscal year. Insider Buying and Selling In other iRhythm Technologies news, EVP Daniel G. Wilson sold 1,261 shares of the firm’s stock in a transaction that occurred on Thursday, February 29th. The stock was sold at an average price of $121.96, for a total transaction of $153,791.56. Following the completion of the transaction, the executive vice president now owns 32,967 shares in the company, valued at approximately $4,020,655.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other iRhythm Technologies news, EVP Daniel G. Wilson sold 1,261 shares of iRhythm Technologies stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $121.96, for a total value of $153,791.56. Following the completion of the transaction, the executive vice president now directly owns 32,967 shares of the company’s stock, valued at approximately $4,020,655.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CTO Mark J. Day sold 1,475 shares of the company’s stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $121.96, for a total transaction of $179,891.00. Following the sale, the chief technology officer now owns 64,412 shares in the company, valued at $7,855,687.52. The disclosure for this sale can be found here. Over the last three months, insiders have sold 35,052 shares of company stock worth $4,274,942. Corporate insiders own 0.68% of the company’s stock. iRhythm Technologies Company Profile (Free Report) iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. See Also Five stocks we like better than iRhythm Technologies What Investors Need to Know About Upcoming IPOs MarketBeat Week in Review – 5/13 – 5/17 3 REITs to Buy and Hold for the Long Term Take-Two Interactive Software Offers 2nd Chance for Investors The Role Economic Reports Play in a Successful Investment Strategy Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook Want to see what other hedge funds are holding IRTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report).
05/04 01:32 EST - seekingalpha.com
iRhythm Technologies, Inc. (IRTC) Q1 2024 Earnings Call Transcript
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q1 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President and CEO Brice Bobzien - CFO Conference Call Participants Allen Gong - JPMorgan Malgorzata Kaczor - William Blair Richard Newitter - Truist Marie Thibault - BTIG Joanne Wuensch - Citibank Kallum Titchmarsh - Morgan Stanley Nathan Treybeck - Wells Fargo David Rescott - Baird Bill Plovanic - Canaccord Suraj Kalia - Oppenheimer Operator Hello, and welcome to the iRhythm Technologies, Inc. Q1 2024 Earnings Conference Call. My name is Terry, and I will be the conference operator today.
iRhythm Technologies, Inc. (IRTC) Q1 2024 Earnings Call Transcript
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q1 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President and CEO Brice Bobzien - CFO Conference Call Participants Allen Gong - JPMorgan Malgorzata Kaczor - William Blair Richard Newitter - Truist Marie Thibault - BTIG Joanne Wuensch - Citibank Kallum Titchmarsh - Morgan Stanley Nathan Treybeck - Wells Fargo David Rescott - Baird Bill Plovanic - Canaccord Suraj Kalia - Oppenheimer Operator Hello, and welcome to the iRhythm Technologies, Inc. Q1 2024 Earnings Conference Call. My name is Terry, and I will be the conference operator today.
04/18 16:05 EST - globenewswire.com
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 after the close of trading on Thursday, May 2, 2024. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 after the close of trading on Thursday, May 2, 2024. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
04/08 19:30 EST - accesswire.com
Investors who lost money on iRhythm Technologies, Inc.(IRTC) should contact Levi & Korsinsky about pending Class Action - IRTC
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74832&wire=1 or contact Joseph E. Levi, Esq.
Investors who lost money on iRhythm Technologies, Inc.(IRTC) should contact Levi & Korsinsky about pending Class Action - IRTC
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74832&wire=1 or contact Joseph E. Levi, Esq.
04/08 13:00 EST - accesswire.com
Levi & Korsinsky Notifies iRhythm Technologies, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - IRTC
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74773&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies iRhythm Technologies, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - IRTC
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74773&wire=1 or contact Joseph E. Levi, Esq.
04/08 11:45 EST - accesswire.com
Class Action Filed Against iRhythm Technologies, Inc. (IRTC) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74748&wire=1 or contact Joseph E. Levi, Esq.
Class Action Filed Against iRhythm Technologies, Inc. (IRTC) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74748&wire=1 or contact Joseph E. Levi, Esq.
04/08 10:22 EST - businesswire.com
IRTC DEADLINE TODAY: ROSEN, A RANKED AND LEADING FIRM, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action – IRTC
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of iRhythm Technologies, Inc. (NASDAQ: IRTC) between January 11, 2022 and May 30, 2023, both dates inclusive (the “Class Period”), of the important April 8, 2024 lead plaintiff deadline. SO WHAT: If you purchased iRhythm common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangemen.
IRTC DEADLINE TODAY: ROSEN, A RANKED AND LEADING FIRM, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action – IRTC
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of iRhythm Technologies, Inc. (NASDAQ: IRTC) between January 11, 2022 and May 30, 2023, both dates inclusive (the “Class Period”), of the important April 8, 2024 lead plaintiff deadline. SO WHAT: If you purchased iRhythm common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangemen.
04/08 06:35 EST - accesswire.com
Contact Levi & Korsinsky by April 8, 2024 Deadline to Join Class Action Against iRhythm Technologies, Inc. (IRTC)
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74671&wire=1 or contact Joseph E. Levi, Esq.
Contact Levi & Korsinsky by April 8, 2024 Deadline to Join Class Action Against iRhythm Technologies, Inc. (IRTC)
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74671&wire=1 or contact Joseph E. Levi, Esq.
04/08 06:00 EST - accesswire.com
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in iRhythm Technologies, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against iRhythm Technologies, Inc. ("iRhythm," or "the Company") (NASDAQ:IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 11, 2022 and May 30, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before April 8, 2024.
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in iRhythm Technologies, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against iRhythm Technologies, Inc. ("iRhythm," or "the Company") (NASDAQ:IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 11, 2022 and May 30, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before April 8, 2024.
04/08 05:45 EST - prnewswire.com
Shareholders that lost money on iRhythm Technologies, Inc.(IRTC) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK , April 8, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in iRhythm Technologies, Inc. ("iRhythm Technologies" or the "Company") (NASDAQ: IRTC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of iRhythm Technologies investors who were adversely affected by alleged securities fraud between January 11, 2022 and May 30, 2023.
Shareholders that lost money on iRhythm Technologies, Inc.(IRTC) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK , April 8, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in iRhythm Technologies, Inc. ("iRhythm Technologies" or the "Company") (NASDAQ: IRTC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of iRhythm Technologies investors who were adversely affected by alleged securities fraud between January 11, 2022 and May 30, 2023.
04/08 05:11 EST - zacks.com
iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
04/08 04:40 EST - accesswire.com
Levi & Korsinsky Reminds iRhythm Technologies, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 8, 2024 - IRTC
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74655&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds iRhythm Technologies, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 8, 2024 - IRTC
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74655&wire=1 or contact Joseph E. Levi, Esq.
04/07 19:20 EST - accesswire.com
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of iRhythm Technologies, Inc.(IRTC) Shareholders
NEW YORK, NY / ACCESSWIRE / April 7, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74634&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of iRhythm Technologies, Inc.(IRTC) Shareholders
NEW YORK, NY / ACCESSWIRE / April 7, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74634&wire=1 or contact Joseph E. Levi, Esq.
04/07 18:40 EST - accesswire.com
Levi & Korsinsky Reminds iRhythm Technologies Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 8, 2024 - IRTC
NEW YORK, NY / ACCESSWIRE / April 7, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74622&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds iRhythm Technologies Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 8, 2024 - IRTC
NEW YORK, NY / ACCESSWIRE / April 7, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74622&wire=1 or contact Joseph E. Levi, Esq.
04/07 18:10 EST - accesswire.com
FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in iRhythm Technologies, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against iRhythm Technologies, Inc. ("iRhythm," or "the Company") (NASDAQ: IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 11, 2022 and May 30, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before April 8, 2024.
FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in iRhythm Technologies, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against iRhythm Technologies, Inc. ("iRhythm," or "the Company") (NASDAQ: IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 11, 2022 and May 30, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before April 8, 2024.
04/07 07:07 EST - accesswire.com
Shareholders of iRhythm Technologies, Inc. Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights - IRTC
NEW YORK, NY / ACCESSWIRE / April 7, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74580&wire=1 or contact Joseph E. Levi, Esq.
Shareholders of iRhythm Technologies, Inc. Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights - IRTC
NEW YORK, NY / ACCESSWIRE / April 7, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74580&wire=1 or contact Joseph E. Levi, Esq.
04/06 19:01 EST - accesswire.com
iRhythm Technologies, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights - IRTC
NEW YORK, NY / ACCESSWIRE / April 6, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74565&wire=1 or contact Joseph E. Levi, Esq.
iRhythm Technologies, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights - IRTC
NEW YORK, NY / ACCESSWIRE / April 6, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irhythm-technologies-lawsuit-submission-form?prid=74565&wire=1 or contact Joseph E. Levi, Esq.